aspsirna0569 details

Purple = Wild vs mutant target sequence along with mutation information
Brown= Wild vs ASP-siRNA description along with positional differnece between two
Light pink= ASP siRNA efficacy for mutant vs wild allele
Green= Wild siRNA efficacy for Wild vs Mutant allele
siRNA Id:aspsirna0569
siRNA Name: LM2
Gene:Amyloid beta (A4) precursor protein(APP)
Disease:Alzheimers disease
Wild allele/target (5'->3'): GACAGUGAUCGUCAUCACCUU
Mutant allele/target (5'->3'):GACAGUGAUCAUCAUCACCUU
Target Mutation: c.2149G>A,p.Val717Ile
Wild siRNA (As strand):CUGUCACUAGCAGUAGUGGAA
ASP-siRNA (As strand):CUGUCACUAGUAGUAGUGGAA
Mismatch position in siRNA: U11C
Mutant allele (5'->3'): GACAGUGAUCAUCAUCACCUU
ASP-siRNA (As strand):CUGUCACUAGUAGUAGUGGAA
ASP-siRNA efficacy for mutant allele:64
Wild allele (5'->3'): GACAGUGAUCGUCAUCACCUU
ASP-siRNA (As strand):CUGUCACUAGUAGUAGUGGAA
ASP-siRNA efficacy for wild allele:67
Percentage discrimination for ASP-siRNA:-3
Wild allele (5'->3'): GACAGUGAUCGUCAUCACCUU
Wild siRNA (As strand):CUGUCACUAGCAGUAGUGGAA
Wild sirna efficacy for wild allele:NA
Wild allele (5'->3'): GACAGUGAUCGUCAUCACCUU
ASP-siRNA (As strand):CUGUCACUAGUAGUAGUGGAA
Wild sirna efficacy for mutant allele:NA
Percentage discrimination for wild siRNA:NA
Concentration:100pmol
Orientation:Sense
Mismatch in:siRNA
UniProt ID: P05067
Target sequence: AGCGACAGUGAUCGUCAUCACCU
Genbank Accesion: NM_000484.3
Cell-line: CHO
Experimental technique used: RT-PCR
Transfection method: Lipofectamine 2000
siRNA expression method: Epicentre Technologies
Post-transfection duration: 48 hours
OMID ID: 104300
KEGG disease ID:H00056
Reference:16426772

.
.
.
.
.
.
.
.
.
.
.

.

.

.